ImmuCell Corporation (ICCC)
ICCC moved a median of 0.00% 30 minutes after news, and -0.26% by the close. How ICCC actually reacts to news — the realized, point-in-time move the market made, measured across 159 labeled events over the last three years with zero look-ahead.
ICCC’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 39% | 98 |
| 30-min | 0.00% | 42% | 138 |
| 60-min | +0.02% | 51% | 150 |
| to close | -0.26% | 43% | 159 |
| Middle 50% of ICCC reactions | -1.62% to +1.32% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 159 |
Half of all ImmuCell Corporation news events land between -1.62% and +1.32% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ICCC moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ICCC's baseline. Nothing else.
Recent ICCC events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K IMMUCELL CORP /DE/ For: Oct 12 | SEC filing · Form 8-K | SEC EDGAR | -2.22% | +0.00% | |
| ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results | Press release | GlobeNewswire | -2.22% | +0.00% | |
| Form 10-Q IMMUCELL CORP /DE/ For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.80% | -6.25% | |
| Form 8-K IMMUCELL CORP /DE/ For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | -2.80% | -6.25% | |
| ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026 | Press release | GlobeNewswire | -2.80% | -6.25% | |
| ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026 | Press release | GlobeNewswire | +0.00% | +0.46% | |
| Form 8-K IMMUCELL CORP /DE/ For: Jul 09 | SEC filing · Form 8-K | SEC EDGAR | +1.05% | -5.06% | |
| ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results | Press release | GlobeNewswire | +1.05% | -5.06% | |
| Form 8-K IMMUCELL CORP /DE/ For: Jun 11 | SEC filing · Form 8-K | SEC EDGAR | — | -1.11% | |
| Form 8-K IMMUCELL CORP /DE/ For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.81% | |
| Form 10-Q IMMUCELL CORP /DE/ For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +3.35% | +6.19% | |
| Form 8-K IMMUCELL CORP /DE/ For: May 14 | SEC filing · Form 8-K | SEC EDGAR | +3.35% | +6.19% | |
| ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026 | Press release | GlobeNewswire | +3.35% | +6.19% | |
| Form 10-K/A IMMUCELL CORP /DE/ For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | -0.84% | |
| Form 8-K IMMUCELL CORP /DE/ For: May 08 | SEC filing · Form 8-K | SEC EDGAR | -0.92% | +3.17% | |
| ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026 | Press release | GlobeNewswire | +0.00% | -5.18% | |
| Form DEF 14A IMMUCELL CORP /DE/ For: Jun 11 | SEC filing · Form DEF | SEC EDGAR | — | +4.44% | |
| Form 8-K IMMUCELL CORP /DE/ For: Apr 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +6.18% | |
| Form PRE 14A IMMUCELL CORP /DE/ For: Jun 11 | SEC filing · Form PRE | SEC EDGAR | +0.00% | -1.30% | |
| ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors | Press release | GlobeNewswire | +0.00% | +6.18% | |
| Form 8-K IMMUCELL CORP /DE/ For: Apr 08 | SEC filing · Form 8-K | SEC EDGAR | +3.70% | +6.52% | |
| ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results | Press release | GlobeNewswire | +3.70% | +6.52% | |
| Form 10-K IMMUCELL CORP /DE/ For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | — | -0.78% | |
| Form 8-K IMMUCELL CORP /DE/ For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | — | +1.65% | |
| ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board | Press release | GlobeNewswire | — | +1.65% | |
| Form 8-K IMMUCELL CORP /DE/ For: Mar 04 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.09% | |
| ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025 | Press release | GlobeNewswire | +0.00% | -1.09% | |
| ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025 | Press release | GlobeNewswire | +0.00% | +3.68% | |
| Form 8-K IMMUCELL CORP /DE/ For: Feb 09 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.60% | |
| Form 8-K IMMUCELL CORP /DE/ For: Jan 27 | SEC filing · Form 8-K | SEC EDGAR | — | -4.42% | |
| Form 8-K IMMUCELL CORP /DE/ For: Jan 08 | SEC filing · Form 8-K | SEC EDGAR | +2.88% | -1.59% | |
| ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 | Press release | GlobeNewswire | +2.88% | -1.59% | |
| ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus | Press release | GlobeNewswire | — | -1.73% | |
| Form 8-K IMMUCELL CORP /DE/ For: Dec 24 | SEC filing · Form 8-K | SEC EDGAR | +3.84% | +0.49% | |
| ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® | Press release | GlobeNewswire | — | +0.00% | |
| ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2025 | Press release | GlobeNewswire | — | -0.65% | |
| Form 8-K IMMUCELL CORP /DE/ For: Oct 29 | SEC filing · Form 8-K | SEC EDGAR | +1.30% | +2.44% | |
| ImmuCell Announces Onboarding of New CEO and Related Management Changes | Press release | GlobeNewswire | +1.30% | +2.44% | |
| Form 8-K IMMUCELL CORP /DE/ For: Oct 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.61% | |
| ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025 | Press release | GlobeNewswire | +0.00% | +0.61% | |
| Form 8-K IMMUCELL CORP /DE/ For: Sep 29 | SEC filing · Form 8-K | SEC EDGAR | +3.91% | +3.13% | |
| ImmuCell Announces Selection of its Next President and CEO | Press release | GlobeNewswire | -0.80% | +0.00% | |
| Form 8-K IMMUCELL CORP /DE/ For: Aug 20 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.08% | |
| Form 10-Q IMMUCELL CORP /DE/ For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | — | -13.92% | |
| Form 8-K IMMUCELL CORP /DE/ For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | — | -13.92% | |
| ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025 | Press release | GlobeNewswire | — | -13.92% | |
| Form 8-K IMMUCELL CORP /DE/ For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.80% | |
| ImmuCell Announces Bank Debt Refinancing | Press release | GlobeNewswire | +0.00% | -1.80% | |
| ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025 | Press release | GlobeNewswire | — | -1.13% | |
| Form 8-K IMMUCELL CORP /DE/ For: Jul 09 | SEC filing · Form 8-K | SEC EDGAR | +0.75% | +0.90% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ICCC section they belong to.
Where else ICCC is measured.
ICCC earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. - Ordinary Shares (GLMD) | 159 | -1.80% | 36% |
| GT Biopharma, Inc. (GTBP) | 159 | -0.91% | 32% |
| CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN) | 158 | -1.25% | 25% |
| NeuroMetrix, Inc. (NURO) | 157 | -0.49% | 30% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is ImmuCell Corporation's median reaction calculated?
Every labeled ICCC news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 159 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 42% of ICCC's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ICCC's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.